Update shared on18 Jun 2025
Subject: Chemours Raises Q2 2025 Outlook Amid Surging Refrigerant Demand and Resilient Segment Performance
Chemours Company (NYSE: CC) has delivered a bullish Q2 2025 outlook revision, driven by stronger-than-expected performance across its Thermal & Specialized Solutions (TSS) and Advanced Performance Materials (APM) segments. While the Titanium Technologies (TT) business faces temporary headwinds, the company maintains a solid overall growth trajectory for the quarter.
🔹 Segment Highlights
Thermal & Specialized Solutions (TSS):
- Net Sales: Expected to rise ~25% sequentially, driven by robust demand for Opteon™ Refrigerants, underpinned by the U.S. AIM Act’s push for low-global warming potential refrigerants.
- Adjusted EBITDA: Forecast to climb nearly 40%, reflecting strong volume and pricing leverage.
Advanced Performance Materials (APM):
- Adjusted EBITDA: Set to increase ~25% sequentially, aided by improved cost performance.
- Net Sales: Remain in line with previous expectations of low-teens sequential growth.
Titanium Technologies (TT):
- Net Sales: On track for high single-digit sequential growth.
- Adjusted EBITDA: Expected to decline ~15%, impacted by:
- $15 million in added costs from using high-cost ore feedstock (due to rail line service interruptions).
- $10 million in other one-time operational disruptions at U.S. sites.
🔸 Company-Wide Outlook
- Consolidated Net Sales: Now seen at the high end of the original range, with mid-teens sequential growth.
- Adjusted EBITDA: Revised upward to $215–$225 million.
- Free Cash Flow: Projected to remain positive in Q2.
- Corporate Costs: Slightly elevated due to ongoing New Jersey litigation as part of the company's legacy resolution strategy.
🧭 Final Thoughts
Chemours is navigating operational hurdles in its TT segment while capitalizing on regulatory tailwinds and structural demand in refrigerants and advanced materials. The revised Q2 outlook highlights resilience, strategic agility, and operational strength, particularly in the face of temporary logistical disruptions.
With margin expansion in core growth areas and continued positive free cash flow, Chemours remains well-positioned to deliver value in the near term—making it one to watch closely as regulatory trends and industrial innovation continue to shape the chemicals landscape.
Disclaimer
The user WaneInvestmentHouse has a position in NYSE:CC. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.